These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1595725)

  • 1. Perspective on sterile compounding practices and the draft guidelines.
    Tormo VJ
    Am J Hosp Pharm; 1992 Apr; 49(4):946-7. PubMed ID: 1595725
    [No Abstract]   [Full Text] [Related]  

  • 2. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 3. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 4. Upgrading quality assurance for pharmacy-prepared sterile products.
    Zellmer WA
    Am J Hosp Pharm; 1991 Nov; 48(11):2387-8. PubMed ID: 1746571
    [No Abstract]   [Full Text] [Related]  

  • 5. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Draft technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. American Society of Hospital Pharmacists, Council on Professional Affairs.
    Am J Hosp Pharm; 1993 Jul; 50(7):1440-52. PubMed ID: 8362882
    [No Abstract]   [Full Text] [Related]  

  • 8. Essential elements of quality control.
    Boylan JC
    Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respecting the risks of sterile compounding.
    Thompson RW; Belisle C
    Am J Health Syst Pharm; 2015 Aug; 72(15):1269. PubMed ID: 26195651
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices.
    Brzozowski DF; Hale KM; Segal R; Mirtallo JM
    Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality control in the hospital pharmacy].
    Kok JF
    Pharm Weekbl; 1968 Apr; 103(17):486-505. PubMed ID: 5665060
    [No Abstract]   [Full Text] [Related]  

  • 13. ASHP guidelines on compounding sterile preparations.
    American Society of Health System Pharmacists
    Am J Health Syst Pharm; 2014 Jan; 71(2):145-66. PubMed ID: 24375608
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality assurance for pharmacy-prepared sterile products in hospitals and home infusion facilities.
    Klein C
    Am J Health Syst Pharm; 1996 Nov; 53(21):2581. PubMed ID: 8913385
    [No Abstract]   [Full Text] [Related]  

  • 15. ASHP invitational conference on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1991 Nov; 48(11):2391-7. PubMed ID: 1746572
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 18. National survey of quality assurance activities for pharmacy-compounded sterile preparations.
    Morris AM; Schneider PJ; Pedersen CA; Mirtallo JM
    Am J Health Syst Pharm; 2003 Dec; 60(24):2567-76. PubMed ID: 14735774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compounding practices in Iran.
    Goodarzi N; Niknam S; Akbarzadeh T; Gholami K
    Int J Pharm Compd; 2014; 18(2):112-6. PubMed ID: 24881113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.